Heritage Global Partners is selling surplus pharmaceutical and biotech laboratory equipment from Amgen. Biotechnology firm Amgen was established in 1980 and now operates in around 100 countries and regions across the world. The firm specialises in the development, manufacture and delivery of innovative medicines for serious illnesses. Amgen focuses on cardiovascular disease, bone health, neuroscience, oncology, nephrology and inflammation, developing medicines for conditions with limited treatment options.
The online auction opens on the 24th of August and closes on the 25th of August, The assets are located in South San Francisco, California and include: Applikon EZCONTROL pilot plant 20L fermenter with ez-Control; Agilent 1200 HPLC systems; Genscript AmMag SA-1012 semi-automated protein purification system; Applied Biosystems MagMax Express 96 magnetic particle processor; Wyatt Technology Calypso-II WCG3-01 biomolecular interaction analysis system; Thermo Scientific Q-Exactive High-Resolution Accurate-Mass LC-MS Hybrid Quadrupole-Orbitrap mass spectrometer; Eksigent microLC 200 HPLC system; Agilent G5404B microplate labeler; SPEX SamplePrep 2010 Geno/Grinder automated tissue homogenizer; ICX Technologies sensiQ pioneer biomolecular interaction analyzer; Malvern Omnisec Multi-Detector GPC/SEC system; Brooks SCM1000-4 microplate and tube based sample prep instrument; Beckman Coulter Optima XPN-80 ultracentrifuge; Molecular Devices plate readers; freezers; centrifuges; biosafety cabinets and much more.
Asset advisory and full-service auction firm Heritage Global Partners operates across more than 25 industries, including the oil and gas, pharmaceutical, automotive and food and beverage sectors. The firm conducts around 150-200 auctions every year – ranging from single asset dispositions to entire turnkey facilities and complete factories.
For further information about this, or any other Heritage Global Partners auction, please visit: